Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (4719)	8/4/1998 12:06:00 AM
From: Brander	Respond to of 9523

"Can you spot the tiny error?" Innoncent bystander Merck--which one wins out? Free advertising for a blockbuster drug Merck has nothing to do with, or bad pr for putting a high price tag on a blocbuster drug Merck has nothing to do with? hehehe...funny :-) Brad

To: BigKNY3 who wrote (4719)	8/4/1998 1:03:00 AM
From: flickerful	Read Replies (1) \| Respond to of 9523

where's waldo? actually, this tiny little error by resident "expert", Carl A. Schnaitman certainly doesn't prevent him from asserting in his editorial some very nearly, quasi- universal truths... something not easily said of the other vehicles comprising the viagra media juggernaut. after all, who are we to argue There is no question that Merck should recover its development costs for Viagra or that is should be allowed to make a profit....Merck [would] receive a giant windfall. moreover, it is entirely possible Merck[may have] greatly under estimated [viagra's] potential market. correct? what's a tiny little error after all.... boy....that merck and its predatory pricing.